CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Breast Cancer

Oncology NEWS International. Vol. 19 No. 5
Focus on Breast Cancer 

State breast cancer screening programs struggle financially

By KATHLYN STONE | May 17, 2010

There's no shortage of controversy when it comes to mammography-based breast cancer screening. Most recently, investigators at the Cochrane Centre in Copenhagen published yet another analysis of screening programs and declared that there was no evidence that screening saves lives.

Mammography screening advocates were quick to point out flaws in the Nordic research, just as they were quick to criticize the U.S. Preventive Task Force last year when it recommended raising the beginning screening age from 40 to 50 (British Medical Journal online, March 24, 2010, and March 30, 2010).

But this debate may be academic if women don't have access to any screening services at all: The prolonged U.S. recession has put mammogram and other cancer screening programs at risk for closure. Rhode Island's free screening program ran out of money in early 2010, forcing it to discontinue offering services until federal funding for the program is replenished in July. California eliminated its no-cost "Every Woman Counts" mammograms to low-income women under age 50 in 2010 and placed a six-month freeze on new enrollments. The screening program run by the state of New York also saw its funding shrink in 2009 because of $3.5 million in cuts to the state's budget.

“The prolonged U.S. recession has put mammogram and other cancer screening programs at risk for closure.”
— Donald A. Berry, PhD

Compounding the problem is that more women, because of job losses, loss of healthcare insurance, or other financial hardships, are now eligible for free screening. One of the factors in the temporary closure of the Rhode Island program was that the state was faced with a 50% rise in demand for screenings that it could not support.

There is no national database to compile information on the states that have reduced or eliminated breast cancer screening programs, but cuts are definitely taking place from coast to coast.

While lack of finances is the main reason for closure, free screening programs are also looking at scientific evidence and expert guidelines to help them determine if screening programs are worthwhile.

"Most states are looking at new evidence, especially that having to do with mammograms," said Joseph Bailes, MD, chair of the ASCO government relations committee.

But "whether states implement the U.S. Preventive Task Force's guidelines remains up in the air." he said.

Minnesota: A case study

The Sage Screening Program in Minnesota is a perfect example of a program that is experiencing major ups and downs because of tough economic times. Free screenings barely survived state budget cuts and severe midyear "unallotments" made by the governor to some Minnesota Department of Health (MDH) programs.

The Sage Screening Program covers the cost of mammograms and cervical cancer screenings that are free to uninsured women or those who have copays through their private insurer. Sage is funded by the CDC's National Breast and Cervical Cancer Early Detection Program, the Susan G. Komen Foundation, and other charitable organizations as well as the state.

Sage follows the American Cancer Society (ACS) guidelines that call for annual mammograms for women 40 and over and for younger women with symptoms or special health risks, including a family history of breast cancer. Sage also receives in-kind support from the ACS.

According to Jonathan Slater, PhD, chief of the MDH Cancer Control Section, 137 cases of breast cancer were detected among the more than 18,200 Minnesota women screened through the Sage program in 2009. Thus about 1 in every 138 screening mammograms resulted in a diagnosis of cancer.

David Arons, government relations director for the ACS in Minnesota, was among the advocates who helped shield Sage from larger state budget cuts. He said MDH Commissioner Sanne Magnan, MD, also deserved kudos. "She stood up for [Sage] last year during the budget process," he said.

'Short-sighted' thinking

Cutting screening to save money is very "short-sighted" thinking, Dr. Bailes said. "Diagnosing a tumor early is a lot less costly to the healthcare system compared with treating someone with an advanced disease," he noted. In 2007, the CDC's National Breast and Cervical Cancer Early Detection Program was reauthorized through fiscal year 2011. The program provides Pap tests and other screenings for qualified women aged 18 to 64 and mammograms for qualified women aged 40 to 64. To qualify, women must be uninsured and have annual incomes lower than 250% of the federal poverty level.

It remains to be seen what effect the healthcare reform law will have on breast cancer screening. The law will not be fully implemented until 2014, but some provisions, such as the elimination of private plan copays for screening tests, take effect sooner. How the law is implemented will also impact screening availability.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Barbara Brusatori | July 28, 2010 1:34 PM EDT

There needs to be more follow up when there are abnormalities in the mamograms.  I had a breast biopsy on my left breast which turned out to be stage III invasive ductal carcinoma triple negative breast cancer .  In my right breast there are several microcalcifications  but more of them.  I also had abnormal mamograms  in my left breast   ever since 1992 when I had my first surigal breast biopsy.  So why don't they do more follow up on these abnormalities?

by Sherri Tenpenny | May 31, 2010 3:20 PM EDT

Diagnosing a tumor is less costly? how about diagnosing a concern and address it before it turns into a tumor? Breast thermography has been doing that for >30 years. Time for conventional medicine to look at those studies and do a better job with true PREVENTION, not just "find it early" methods.






 
RELATED CONTENT

Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
June 19, 2013
ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
June 18, 2013
Postmenopausal Hormone Receptor–Positive Advanced Breast Cancer
ONCOLOGY,  June 17, 2013
Fertility Preservation and Breast Cancer: A Complex Problem
ONCOLOGY,  June 17, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
  • ASCO: PD-L1 Antibody Elicits Durable Response in RCC
  • RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • Radiation-Induced Enteritis: Incidence, Mechanisms, and Management
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter



CancerNetwork on Facebook
 
SearchMedica SEARCH RESULTS

Find peer-reviewed literature and websites for practicing medical professionals

CME on Breast Cancer
Evidence on Breast Cancer
Guidelines on Breast Cancer
Patient Education on Breast Cancer
Clinical Trials on Breast Cancer
Practical Articles on Breast Cancer
Research and Reviews on Breast Cancer
All "Breast Cancer" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy